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Nitric oxide in unilateral ureteral obstruction: Effect on re- struction is seen in 3.9% of autopsies [1], with its true
gional renal blood flow. incidence being considerably higher, as many of the
Background. Ureteral obstruction (UO) is characterized by causes resolve over time or are successfully treated. Thereduced blood flow and loss of tissue mass in the involved
clinical presentation depends on the speed of onset andkidney(s). Vasoactive mediators interact to produce an initial
hyperemia, followed by a sustained decrease in renal blood whether obstruction is complete or incomplete.
flow in the obstructed kidney. Nitric oxide (NO) has been Acute obstruction presents with intense abdominal
shown to play a central role in the acute hyperemic response pain and an associated decrease in function in the ob-
to UO. Its role in the reduced perfusion of prolonged UO is
structed kidney(s). As obstruction persists, there is dila-less studied.
tion of the kidney and gradual loss of renal tissue mass.Methods. Ureteral obstruction was achieved by ligation of
the distal left ureter and maintained for 24 hours. Blood flow Following the onset of obstruction, there may be a tran-
was studied in untreated animals and after the administration sient increase in blood flow to the obstructed kidney.
of the NO synthase (NOS) inhibitor N-mono-methyl l-arginine This soon declines to below resting values and continuesand the NO donor sodium nitroprusside. Tissue was collected
to decrease as obstruction persists [2]. It is in the contextfor localization and quantitation of NOS. Serum and renal
of this prolonged reduction in blood flow that corticaltissue l-arginine levels were measured in control and UO set-
tings. tissue loss occurs.
Results. Blood flow in the obstructed kidney diminished to A number of vasoactive mediators have been impli-
approximately 50% of control values after 24 hours of UO.
cated in these vascular changes, including prostaglandinsNOS blockade led to a further decrease in blood flow. Supple-
[3], the renin-angiotensin system [4], and more recentlymentation with exogenous nitrates restored renal blood flow to
levels approaching control values. Serum and tissue l-arginine nitric oxide (NO) [5, 6]. NO was originally termed endo-
levels did not change with UO. NOS expression was seen to thelium-derived relaxation factor (EDRF) because of its
increase with increasing duration of obstruction, with staining potent vasodilatory action [7]. It has also been shown tomost pronounced in the renal tubules.
have important functions as a neurotransmitter and bothConclusions. NO plays a vasodilatory role even in the hypo-
stimulatory and inhibitory effects on programmed cellperfusion of prolonged UO. The administration of exogenous
nitrates has a restorative effect on blood flow, suggesting thera- death [8]. It is a highly reactive gas, formed when the
peutic potential in UO. semi-essential amino acid l-arginine is converted to
l-citrulline, by the action of the NO synthases (NOSs).
Three isoforms of NOSs have been identified, with the
Ureteral obstruction (UO) is a disease process that endothelial constitutive (eNOS) and inducible (iNOS)
may result from a diversity of congenital or acquired forms being involved in renal vascular responses [9].
conditions, ranging from calculi to strictures and to in- Increased NO activity has been implicated in the initial
flammatory processes and malignancies. Evidence of ob- hyperemic response to UO [5, 10], but why this effect is
not sustained in prolonged obstruction remains unclear.
It has been suggested that NO production declines withKey words: quantitative autoradiography, nitric oxide synthase, vasodi-
lation, acute hyperemia, obstructed kidney. depletion of l-arginine substrate or decreased NOS ac-
tivity or that the vascular endothelium becomes less re-
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how supplementation with an exogenous source of ni- AA6300. Serum samples (2 mL) from control rats and
trates might affect renal blood flow. rats subjected to 24 hours of ureteral obstruction were
deproteinized with sulfosalicylic acid, and amino acid
concentrations were quantitated colorimetrically by re-METHODS
action with ninhydrin. A similar technique was in kidneys
Experimental groups and interventions from control and 24-hour obstructed rats. Tissue was
All experiments were performed in adult male Sprague- collected and homogenized in phosphate-buffered saline
Dawley rats (300 to 400 g). Animals were allowed free ac- (PBS). Samples were then deproteinized as mentioned
cess to food and water, with routine administration of anal- previously, and concentrations were determined per
gesia in the postoperative period. Six groups were studied, gram of initial total protein.
with six rats per group. Group 1 animals had a midline
Immunohistochemistrylaparotomy and manipulation of the left ureter performed.
Group 2 rats were pretreated with the nonspecific NOS Paraffin-embedded kidney sections were cut at 4 mm.
inhibitor N-monomethyl l-arginine (LNMMA; Sigma Slides were deparaffinized in xylene and alcohol, with
Laboratories, St. Louis, MO, USA) at a dose of 10 mg/kg endogenous peroxidase activity being quenched in 3%
10 minutes prior to laparotomy. Group 3 animals were hydrogen peroxide for 10 minutes. Slides were incubated
infused with the nitrate donor sodium nitroprusside (SNP) in primary antibody for iNOS and eNOS (both from
at a rate of 0.5 mg/kg/min (equivalent to the treatment Transduction Laboratories, San Diego, CA, USA), in
dose used in congestive cardiac failure; product informa- concentrations of 1:100 and 1:200, respectively, over one
tion sheet). This dose was chosen because it was felt that hour at room temperature; negative control slides were
it would achieve a therapeutic effect without altering the incubated in bovine serum albumin (BSA) antibody
mean arterial blood pressure (animal license did not allow buffer without primary antibody. Slides were washed in
for the performance of dose-response experiments). PBS for 4 3 5 minutes and incubated for a further 30
Groups 4 to 6 represented similar treatment groups (that minutes at room temperature in 1:1000 anti-mouse sec-
is, untreated or pretreated with LNMMA or SNP, re- ondary antibody. Slides were developed in 3,39-diamino-
spectively). In these groups, however, UO was achieved benzidine tetrahydrochloride (DAB) for seven minutes
by ligation of the distal left ureter with 2/0 silk suture. and counterstained with methyl green. Areas of staining
LNMMA was administered 20 minutes prior to the es-
were identified, and intensity of staining was scored from
tablishment of UO. Sodium nitroprusside infusion was
0 to 3 (0 5 no staining, 1 5 weak positive, 2 5 moderatecommenced 20 minutes prior to the determination of
staining, and 3 5 strongly positive staining). All slidesblood flow. Blood flow was determined in all groups;
were viewed and scored by three blinded observers.kidney sections and serum were taken from control ani-
mals and after 24 hours of obstruction for estimation of Western blotting
l-arginine concentration. Further kidney sections were
Western blot analysis was used to determine the rela-stored in formalin for immunohistochemistry. Kidney
tive expression of iNOS and eNOS in renal tissue. Onetissue samples were also collected for protein analysis
hundred fifty milligram samples of renal tissue were incu-(Western blot) from rats in whom UO was sustained for
bated in homogenization buffer comprised of HEPES0, 10, and 30 minutes and 4 and 24 hours (N 5 4 per
40 mmol/L, sucrose 32 mmol/L, dithiothreitol (DTT) 1group).
mmol/L, leupeptin 10 mg/mL, soybean trypsin inhibitor
10 mg/mL, and aprotinin 2 mg/mL [12], and were furtherBlood flow measurement
eluted using an ultrasound sonicator. Protein content inBlood flow was studied using a quantitative autoradio-
the homogenates was then quantitated using the Brad-graphic technique [11]. Briefly, this involved intravenous
ford assay protein assay technique [13]. Fifty microgramsinfusion of 15 mC of a freely diffusible 14C iodantipyrine
of protein were added per well, and proteins were re-(Sigma-Aldrich Ireland Ltd., Dublin, Ireland) radio-
solved on a 12% polyacrylamide gel at 140 V for 80tracer over 15 seconds under halothane anesthesia. At
minutes. Proteins were then transferred from the gelthe same time, serial arterial blood samples were taken
to nitrocellulose membrane at 100 V over 80 minutes.to allow the determination of radiotracer concentration
Membranes were incubated in blocking buffer (5% BSAin the blood, and combined with the distribution of radio-
in PBS 1 0.1% Tween) at 48C overnight. They were thentracer in the tissues, regional renal blood flow was calcu-
incubated with either 1:1000 anti-eNOS (Transductionlated. Femoral artery cannulation allowed arterial pres-
Laboratories) or 1:2000 anti-iNOS (Transduction Labo-sure monitoring throughout the experiment.
ratories) for one hour at room temperature, washed for
L-Arginine levels 5 3 5 minutes with PBS 1 0.1% Tween solution, and
then incubated for a further one hour at room tempera-l-Arginine concentrations were determined by ion ex-
change column chromatography, using the Beckman ture with 1:5000 horseradish peroxidase-conjugated anti-
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Fig. 1. Effects of pretreatment with the nitric oxide synthase (NOS) inhibitor LNMMA on (A) cortical blood flow and (B) medullary blood flow.
Regional renal blood flow was measured using quantitative autoradiography in control animals and following 24 hours of UO in the obstructed
kidney, untreated ( ) or pretreated with N-monomethyl l-arginine (L-NMMA; ) 10 mg/kg (N 5 6 rats per group). *P , 0.05 vs. untreated
control; †P , 0.05 vs. untreated 24-hour UO.
mouse antibody (Transduction Laboratories). Blots were Nitric oxide donors restore renal blood flow in UUO
washed a further 5 3 5 minutes with PBST developed Sodium nitroprusside infusion (0.5 mg/kg/min) had no
using ECL detection kit (Amersham, Buckinghamshire, effect on blood pressure (105 6 7 mm Hg in control rats
UK) and exposed to radiographic film. Radiological den- vs. 102 6 8 mm Hg in SNP treated), and neither did
sities were measured using TK/20 analyzer (Imaging Re- it have any marked effect on basal renal blood flow.
search, Ontario, Canada). Following 24-hour UO, the administration of SNP was
seen to increase renal blood flow in the cortex by 61%
Statistical analysis and also led to a 56% increase in medullary blood flow
(Fig. 2).Blood flows were measured in mean 6 SEM. and
compared using Student t test. l-arginine and NOS levels
Serum and renal tissue L-arginine levels arewere measured as mean 6 SD and were compared using
unchanged in UUOStudent t test. Significance was determined as P , 0.05.
There was no significant difference in serum l-arginine
levels between control animals (252 6 34 mmol/L) and
animals subjected to 24 hours UO (261 6 48 mmol/L,RESULTS
N 5 3 animals per group). There was no statisticallyNitric oxide synthase inhibition reduced renal blood
significant change in tissue levels of l-arginine after 24flow in UUO
hours in the obstructed (1983 6 1189 mmol/g) compared
Control blood flow in the renal cortex was measured with the control kidney (2588 6 917 mmol/g, N 5 4 per
at 806 6 63 mL/100 g tissue/min and 373 6 38 mL/100 group, P 5 0.45).
g tissue/min in the medulla. Inhibition of NO production
by LNMMA resulted in a decrease in blood flow in Tubular NOS expression increases in UO
both the cortex (28% decrease) and the medulla (42% Features consistent with proximal tubules were the
decrease) without causing any significant change in blood presence of columnar cells and brush border, whereas
pressure (105 6 7 mm Hg in controls vs. 108 6 12 mm Hg cuboidal or flatter epithelium and a clear lumen without
following 24-h UO). These changes reflect the contribu- brush border were taken to represent distal tubules. Such
tion of NO to renal blood flow in the resting state. Fol- features could also be seen in the dilated tubules of the
lowing 24 hours of UO, a decrease in blood flow com- obstructed kidneys, suggesting that dilation was oc-
pared with control values was seen (39% decrease in the curring predominantly in the distal tubules. In control
cortex, 49% decrease in the medulla). Treatment with kidneys, a faint expression of eNOS and iNOS was seen
LNMMA prior to obstruction resulted in a further 16% in the proximal and distal renal tubules, with no staining
reduction in blood flow in the cortex and a 88% decrease in the glomeruli. After 24 hours of UO, increased expres-
sion of both NOS isoforms was seen in the medullain the medulla after 24 hours of UO (Fig. 1).
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Fig. 2. Sodium nitroprusside (SNP) infusion. Sodium nitroprusside (SNP) infused intravenously at 0.5 mg/kg/min for 20 minutes prior to measure-
ment of blood flow in (A) the renal cortex and (B) the renal medulla. Regional renal blood flow was measured using quantitative autoradiography
in control animals and following 24-hour UO in the obstructed kidney, untreated ( ) or pretreated with SNP 0.5 mg/kg/min ( ). N 5 6 rats per
group). *P , 0.05 vs. untreated control; †P , 0.05 vs. untreated 24-hour UO.
and distal tubules in the cortex, with less staining in the It does imply that during UO, there is either a decrease
in endogenous NO production or increased NO require-proximal tubules (Fig. 3). A similar pattern of increased
NOS staining was seen in the obstructed kidneys pre- ment or a combination of the two. Because of its very
short half-life, direct measurement of NO production intreated with LNMMA.
Using Western blotting, the expression of eNOS and vivo is almost impossible. High levels of endogenous
nitrites and nitrates render estimations from measure-iNOS were both seen to increase gradually with increas-
ing duration of obstruction. Compared with levels in the ment of the generation of NO breakdown products in-
accurate. In practice, indirect measurements, such as se-control kidney, eNOS expression was seen to increase
7-fold after 4 hours of obstruction and 12-fold after 24 rum and tissue levels of l-arginine, measurement of NOS
expression, or the rate of conversion of l-arginine tohours of obstruction. Corresponding increases were seen
in iNOS expression with 4-fold and 12-fold increases l-citrulline are preferred. Studies of bilateral ureteral
obstruction (BUO) have demonstrated decreased serumafter 4 and 24 hours of obstruction, respectively (Fig. 4).
and tissue levels of l-arginine after 24 hours of UO.
There is also impairment in the ability of renal tubular
DISCUSSION
cells to synthesize l-arginine from citrulline following
The technique of quantitative autoradiography has release of BUO compared with control kidneys [17]. In
been established over the past decade for use in measur- this study, we have shown that in unilateral UO, there
ing renal and ureteral blood flow [11, 14]. It has a number is no demonstrable decrease in serum l-arginine, and
of advantages over other techniques of renal blood flow although there may be a slight absolute decrease in tissue
measurement, allowing regional blood flow patterns to l-arginine levels in the obstructed kidney, this does not
be measured to a resolution of 100 mm, with minimal attain statistical significance. Nevertheless, the adminis-
disturbance to the kidney [15]. In this study, it was em- tration of l-arginine in UO has been shown to have a
ployed to show the alterations in cortical and medullary number of protective effects, including a reduction in
blood flow following 24-hour UO. Decreases in blood the infiltration of the kidney with macrophages [18] and
flow were seen following pretreatment with LNMMA in a decrease in tubulointerstitial scarring [19]. Its effect
control and obstructed settings, suggesting that NO retains on renal blood flow is less clear, with some authors dem-
a vasodilatory action during prolonged UO. This is consis- onstrating a significant restorative effect [20] and other
tent with decreases in blood flow observed in the ob- studies failing to show any significant change [16]. Insuf-
structed kidney when NOS is inhibited by L-NAME [16]. ficient NO is unlikely to be due to reduced NOS levels,
Having established that the renal vasculature remains as NOS expression increases as UO persists. Distortion
responsive to endogenous nitrates in UO, our finding of tubules following UO makes their true nature difficult
that the addition of exogenous nitrate in the form of to determine on light microscopy. Histologic inspection
SNP has a marked restorative effect on blood flow in of their epithelium suggests that it occurs predominantly
in distal rather than proximal renal tubules. Increasedthe obstructed kidney, although novel, is not surprising.
Fig. 3. Immunohistochemical staining. Paraffin-embedded kidneys were cut at 4 mm and deparaffinized in xylene and alcohol and immersed in
3% hydrogen peroxide. Slides were incubated with antibody buffer (A) 1:200 mouse anti-eNOS (B–D) or 1:100 mouse anti-iNOS (E–G ) for one
hour and then for 30 minutes in 1:1000 anti-mouse antibody. Sections were stained with 3,39-diaminobenzidine tetrahydrochloride (DAB) and
were counterstained with methyl green. (A) Negative control showing little background activity. (B) Control kidney. (C) Twenty-four–hour UO.
(D) Twenty-four–hour UO, pretreated with L-NMMA. (E) Control kidney. (F) Twenty-four–hour UO. (G) Twenty-four–hour UO, pretreated
with L-NMMA.
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Fig. 3. Continued.
NOS staining following UO is most apparent in these decreases in cofactors for NOS activity or an increase
in inhibitors of NO production. There may also be in-tubules both in the cortex and more diffusely in the
medulla, corresponding with the area of maximal tissue creased NO requirements in UO, and nitrate supplemen-
tation can ameliorate each of these. Further study ofdamage in UO.
Binding studies in renal ischemia reperfusion demon- these factors is likely to provide valuable insight into
the pathophysiology and potential therapeutic strategiesstrate that following the initial increase in blood flow
and NOS activity on reperfusion, during the subsequent against the deleterious effects of UO.
In summary, NO plays an important role in the regula-decrease in blood flow there is reduced NOS activity,
while at the same time, NOS expression remains elevated tion of blood flow in the normal and the diseased kidney.
In UO, the renal vasculature remains responsive to the[21]. From our findings, we propose that a similar process
may occur in UO. Most likely, these are associated with vasodilatory actions of NO, and blood flow changes asso-
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ation factor; eNOS, endothelial nitric oxide synthase; iNOS, inducible
nitric oxide synthase; L-NMMA, N-monomethyl l-arginine; NO, nitric
oxide; NOS, nitric oxide synthase; PBS, phosphate-buffered saline;
SNP, sodium nitroprusside; UO, ureteral obstruction.
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